Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial.

  • Birgitta Lannering
  • Stefan Rutkowski
  • Francois Doz
  • Barry Pizer
  • Göran Gustafsson
  • Aurora Navajas
  • Maura Massimino
  • Roel Reddingius
  • Martin Benesch
  • Christian Carrie
  • Roger Taylor
  • Lorenza Gandola
  • Thomas Björk-Eriksson
  • Jordi Giralt
  • Foppe Oldenburger
  • Torsten Pietsch
  • Dominique Figarella-Branger
  • Keith Robson
  • Marco Forni
  • Steven C Clifford
  • Monica Warmuth-Metz
  • Katja von Hoff
  • Andreas Faldum
  • Véronique Mosseri
  • Rolf Kortmann

Abstract

To compare event-free survival (EFS), overall survival (OS), pattern of relapse, and hearing loss in children with standard-risk medulloblastoma treated by postoperative hyperfractionated or conventionally fractionated radiotherapy followed by maintenance chemotherapy.

Bibliografische Daten

OriginalspracheEnglisch
Aufsatznummer26
ISSN0732-183X
StatusVeröffentlicht - 2012
pubmed 22851561